Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 7/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | MAPK7 | Q13164 | 4/20 | 0.33 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.32 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.32 |
| ▸ | ITGAL | P20701 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17849237 | 0.86 | RORC (0.33) | RORCPARP1MAPK14 | |
| SCHEMBL17849205 | 0.86 | DGAT1 (0.32) | MAPK7MAPK14PKMMAP2K1 | |
| SCHEMBL16623544 | 0.84 | MEN1 (0.32) | MAPK14KMT2A | |
| SCHEMBL16726665 | 0.82 | ALDH2 (0.33) | ITGB2ICAM1ITGALKMT2A | |
| SCHEMBL16623603 | 0.81 | PARP1 (0.36) | RORCPARP1MAP2K1 | |
| SCHEMBL16623468 | 0.81 | MPO (0.31) | — | |
| SCHEMBL16623547 | 0.80 | SYK (0.36) | — | |
| SCHEMBL17849215 | 0.78 | CRBN (0.38) | — | |
| SCHEMBL16726696 | 0.77 | HDAC6 (0.41) | RORCLMNA | |
| SCHEMBL18052610 | 0.77 | MAPK10 (0.41) | MAPK7MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371320-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-06-21 | — | — | US | disclosed |
| US-9371320-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-06-21 | — | — | US | disclosed |